Corr BR, Thomas SM, Haight PJ, Stock E, et al. Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer;
a real world multi-institutional review of practice patterns, efficacy and
tolerability. Gynecol Oncol 2025;201:69-75.
PMID: 40816031
|